SNCA and COVID-19: Our meta-analyses suggested that COVID-19 elevates SNCA expression with the possible aggregation of α-synuclein and the formation of Lewy bodies through the NISP, which would subsequently enhance neurodegeneration, leading to the augmentation of PD onset and progression.